Skyepharma (SKP)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

52.00p
   
  • Change Today:
    -1.25p
  • 52 Week High: 101.50p
  • 52 Week Low: 43.50p
  • Currency: UK Pounds
  • Shares Issued: 46.13m
  • Volume: 58,087
  • Market Cap: £23.99m
  • RiskGrade: 238
  • Beta: 0.29

Latest Deals

Traded Action Notifier PriceAmountValue
29-Apr-13 Transfer From Peter Grant 0.000p 278 £0.00
29-Apr-13 Buy Peter Grant 45.00p 278 £125.10

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
29-Apr-13 Buy Peter Grant 45.00p 278 £125.10
29-Apr-13 Transfer From Peter Grant 0.000p 278 £0.00

Director Shareholdings

Notifier Holding Value*
Jean-Charles Tschudin 137,578 £71,541
Peter Grant 83,763 £43,557
Frank Condella 31,115 £16,180
Alan Bray 6,163 £3,205

Major Shareholders

Notifier** Holding Value*
HBM Healthcare Investments (Cayman) Ltd 10,026,806 £5,213,939
Bank of America Corporation 6,085,115 £3,164,260
HBM BioVentures 4,976,806 £2,587,939
Zazove Associates LLC 4,853,958 £2,524,058
Henderson Global Investors 3,352,104 £1,743,094
Miton Group plc 3,202,104 £1,665,094
OrbiMed Advisors LLC 2,683,952 £1,395,655
D E Shaw & Co L.P 2,617,800 £1,361,256
AXA Investment Managers SA 1,666,750 £866,710
Aviva plc and subsidiaries 1,542,418 £802,057
Barclays Stockbrokers 1,133,104 £589,214
TD Waterhouse Stockbrokers 1,044,375 £543,075

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Skyepharma Market Data

Currency UK Pounds
Share Price 52.00p
Change Today -1.25p
% Change -2.35 %
52 Week High 101.50p
52 Week Low 43.50p
Volume 58,087
Shares Issued 46.13m
Market Cap £23.99m
Beta 0.29
RiskGrade 238

Skyepharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.14% below the market average39.14% below the market average39.14% below the market average39.14% below the market average39.14% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average
Price Trend
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average
Income Not Available
Growth
88.78% below the market average88.78% below the market average88.78% below the market average88.78% below the market average88.78% below the market average
89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average

Skyepharma Dividends

No dividends found

Trades for 22-May-2013

Time Volume / Share Price
15:35 1,881 @ 53.15p
13:28 3,000 @ 52.00p
13:27 10,000 @ 51.00p
12:48 10,000 @ 52.59p
11:20 7,906 @ 54.08p

Skyepharma Key Personnel

CEO Peter Grant

Top of Page